Trending News
News
News
New Insights May Inform Drug-Resistant Tuberculosis Treatment
In the face of growing antibiotic resistance among bacterial infections, scientists have delved into the molecular science behind treatment-resistant tuberculosis.
News
Polymer-Based Nanoparticle May Improve mRNA Cancer Vaccines
A degradable, polymer-based nanoparticle packaging system has shown potential for improving the delivery of mRNA cancer vaccines and vaccines for infectious diseases.
News
Improved Understanding of Immune Complement System Could Help Therapeutic Developments
New research has illustrated that activating the immune complement system can enhance cancer immunotherapies.
News
Ulcerative Colitis Drug Doubles Remission Rates in Clinical Trial
In two Phase 3 clinical trials, a new drug doubled the rate of remission in patients with the inflammatory bowel disease ulcerative colitis.
News
Potential Liver Disease Treatment Identified in Trial
Results from a new clinical trial have identified pegozafermin as a promising treatment for liver damage (fibrosis) related to non-alcoholic steatohepatitis (NASH).
News
Senescence of Stem Cells Reversed With Improved Antioxidant Delivery Method
As we age, our bodies change and degenerate over time in a process called senescence. Stem cells also experience senescence, which presents an issue when trying to maintain cell cultures for therapeutic use.
News
Enzyme From Marine Fungus Could Help Develop Cancer Drugs
Study provides complete roadmap to complex molecule assembly.
News
Common Blood Pressure Drugs Under-Used for Migraine, Study Says
Common blood pressure drugs could be used much more widely, at low cost, to prevent migraine than is the case with current practice, according to new research.
News
Higher Oral Semaglutide Doses Improve Blood Sugar Regulation and Weight Loss
A multicenter, randomized, phase 3b trial, found that once-daily oral semaglutide taken at higher doses of 25mg and 50mg improved regulation of blood sugar levels and weight loss compared to the standard 14 mg dose.
News
New Hair Loss Drug Approved by FDA for Alopecia Areata
LITFULO has been approved by the FDA to treat alopecia areata, an autoimmune disease that causes hair loss on the scalp, face and body.
Advertisement